ArticleMedicina (Kaunas, Lithuania)2023

Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept Switch.

Murat Kucukevcilioglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.